TPH1 catalyzed the reaction of enhanced degradation of tryptophan to serotonin, and its oncogenetic has been discovered in breast cancer, bladder cell carcinoma, and colon cancer [31–33]. This evidence concerns the gene TPH1 and colonic neoplasm.